Cost-Effective Analysis Of Clozapine Compared With Olanzapine, Quetiapine, And Risperidone In The Management Of Patients With Treatment-Resistant Schizophrenia

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1390
https://www.valueinhealthjournal.com/article/S1098-3015(16)01458-3/fulltext
Title : Cost-Effective Analysis Of Clozapine Compared With Olanzapine, Quetiapine, And Risperidone In The Management Of Patients With Treatment-Resistant Schizophrenia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01458-3&doi=10.1016/j.jval.2016.03.1390
First page : A183
Section Title : Mental Health - Clinical Outcomes Studies
Open access? : No
Section Order : 516
Categories :
Tags :
Regions :
ViH Article Tags :